ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2018. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347,903 | -27.3% | 19,371 | -17.7% | 0.00% | 0.0% |
| Q2 2023 | $478,458 | -2.4% | 23,523 | +4.5% | 0.00% | 0.0% |
| Q1 2023 | $490,035 | -30.7% | 22,520 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $706,665 | +22.9% | 22,803 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $575,000 | +24.5% | 22,552 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $462,000 | -20.6% | 22,747 | -3.3% | 0.00% | 0.0% |
| Q1 2022 | $582,000 | -34.2% | 23,514 | -7.7% | 0.00% | 0.0% |
| Q4 2021 | $885,000 | +28.4% | 25,468 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $689,000 | -0.1% | 25,420 | -4.5% | 0.00% | 0.0% |
| Q2 2021 | $690,000 | -0.9% | 26,623 | -17.6% | 0.00% | 0.0% |
| Q1 2021 | $696,000 | -70.6% | 32,299 | -70.7% | 0.00% | -66.7% |
| Q4 2020 | $2,369,000 | +397.7% | 110,188 | +241.1% | 0.00% | +200.0% |
| Q3 2020 | $476,000 | -34.0% | 32,299 | +0.1% | 0.00% | 0.0% |
| Q2 2020 | $721,000 | +37.6% | 32,280 | -13.0% | 0.00% | 0.0% |
| Q1 2020 | $524,000 | -15.8% | 37,103 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $622,000 | -53.5% | 38,280 | 0.0% | 0.00% | -66.7% |
| Q3 2019 | $1,339,000 | -37.3% | 38,280 | +1.2% | 0.00% | -25.0% |
| Q2 2019 | $2,134,000 | -9.7% | 37,823 | +17.0% | 0.00% | -20.0% |
| Q1 2019 | $2,362,000 | +12.0% | 32,340 | -2.2% | 0.01% | 0.0% |
| Q4 2018 | $2,109,000 | -27.2% | 33,060 | +13.9% | 0.01% | -16.7% |
| Q3 2018 | $2,897,000 | +43.6% | 29,034 | +2.3% | 0.01% | +50.0% |
| Q2 2018 | $2,017,000 | -28.7% | 28,394 | +4.4% | 0.00% | -33.3% |
| Q1 2018 | $2,830,000 | -0.1% | 27,187 | -3.4% | 0.01% | 0.0% |
| Q4 2017 | $2,834,000 | +318.0% | 28,140 | +45.1% | 0.01% | +200.0% |
| Q3 2017 | $678,000 | +198.7% | 19,400 | +104.2% | 0.00% | – |
| Q2 2017 | $227,000 | -18.3% | 9,500 | -5.0% | 0.00% | -100.0% |
| Q1 2017 | $278,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |